FirsthandHealth
medRxiv PreprintsInternational19 November 2026

Integrative Multi-Ancestry and Multi-Tissue Fine-Mapping Prioritizes Candidate Causal Genes for Risk of Breast Cancer and Its Subtypes

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Most breast cancer (BC) risk loci identified by genome wide association studies lie in noncoding regions, and traditional transcriptome-wide association studies (TWAS) often prioritize multiple correlated genes per locus. We applied two gene fine-mapping methods, TGVIS and M cTWAS, which jointly model gene expression, splicing and alternative polyadenylation (APA) with direct variant effects, to overall BC, estrogen receptor-negative (ER negative) BC and triple-negative BC (TNBC) in women of European and African ancestry. Using 11 BC-relevant GTEx v10 tissues, we prioritized 31, 13 and 5 candi
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.